Skip to main content

Crowley John F's Form 4 filing

Amicus Therapeutics, Inc. (FOLD) · filed May 3, 2023

Accession no.
0001062993-23-010103
Filed
May 3, 2023
Trade date
May 1, 2023
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 1 non-derivative transaction. Open-market sales total $71.3K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Crowley John FCIK 0001400973Director, Officer (Executive Chairman)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
May 1, 2023Common StockSSaleDisposed−6,044$11.80F1−$71,319.2968,405Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $11.59 to $11.89 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Referenced by the price of 1 transaction in Table I.

Remarks

All transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 7, 2022. In addition to the reported transactions, Mr. Crowley also has approximately 682,224 options outstanding and exercisable at various strike prices.

Read the full filing on SEC EDGAR (opens in a new tab)